{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T20:58:43Z","timestamp":1795121923254,"version":"4.10.3"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,15]],"date-time":"2018-08-15T00:00:00Z","timestamp":1534291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Inflammation and its resolution is under-studied in medicine despite being essential for understanding the development of chronic inflammatory disease. In this review article, we discuss the resolution of inflammation in both a biological and translational context. We introduce the concept of impaired resolution leading to diseases like rheumatoid arthritis, Crohn's disease, and asthma, as well as the cellular and molecular components that contribute to resolution of joint, gut, and lung inflammation, respectively. Finally, we discuss potential intervention strategies for fostering the resolution process, and their implications for the therapy of inflammatory diseases.<\/jats:p>","DOI":"10.1038\/s41467-018-05800-6","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T09:17:11Z","timestamp":1533806231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":412,"title":["Resolution of chronic inflammatory disease: universal and tissue-specific concepts"],"prefix":"10.1038","volume":"9","author":[{"given":"Georg","family":"Schett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,15]]},"reference":[{"key":"5800_CR1","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/ni.3790","volume":"18","author":"MG Netea","year":"2017","unstructured":"Netea, M. G. et al. A guiding map for inflammation. Nat. Immunol. 18, 826\u2013831 (2017).","journal-title":"Nat. Immunol."},{"key":"5800_CR2","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nri3362","volume":"13","author":"CD Buckley","year":"2013","unstructured":"Buckley, C. D. et al. The resolution of inflammation. Nat. Rev. Immunol. 13, 59\u201366 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"5800_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nm.3260","volume":"19","author":"G Schett","year":"2013","unstructured":"Schett, G., Elewaut, D., McInnes, I. B., Dayer, J. M. & Neurath, M. F. How cytokine networks fuel inflammation: toward a cytokine-based disease taxonomy. Nat. Med. 19, 822\u2013824 (2013).","journal-title":"Nat. Med."},{"key":"5800_CR4","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes, I. B. & Schett, G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet 389, 2328\u20132337 (2017).","journal-title":"Lancet"},{"key":"5800_CR5","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1056\/NEJMct1209614","volume":"369","author":"OH Nielsen","year":"2013","unstructured":"Nielsen, O. H. & Ainsworth, M. A. Tumor necrosis factor inhibitors for inflammatory bowel disease. N. Engl. J. Med. 369, 754\u2013762 (2013).","journal-title":"N. Engl. J. Med."},{"key":"5800_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan, C. N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92\u2013101 (2014).","journal-title":"Nature"},{"key":"5800_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/ni1276","volume":"6","author":"CN Serhan","year":"2005","unstructured":"Serhan, C. N. & Savill, J. Resolution of inflammation: the beginning programs the end. Nat. Immunol. 6, 1191\u20131197 (2005).","journal-title":"Nat. Immunol."},{"key":"5800_CR8","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1038\/nprot.2017.044","volume":"12","author":"S Wirtz","year":"2017","unstructured":"Wirtz, S. et al. Chemically induced mouse models of acute and chronic intestinal inflammation. Nat. Protoc. 12, 1295\u20131309 (2017).","journal-title":"Nat. Protoc."},{"key":"5800_CR9","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/978-1-4939-6786-5_27","volume":"1559","author":"W Razawy","year":"2017","unstructured":"Razawy, W. et al. Experimental arthritis mouse models driven by adaptive and\/or innate inflammation. Methods Mol. Biol. 1559, 391\u2013410 (2017).","journal-title":"Methods Mol. Biol."},{"key":"5800_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nature12175","volume":"498","author":"T L\u00e4mmermann","year":"2013","unstructured":"L\u00e4mmermann, T. et al. Neutrophil swarms require LTB4 and integrins at sites of cell death in vivo. Nature 498, 371\u2013375 (2013).","journal-title":"Nature"},{"key":"5800_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/89759","volume":"2","author":"BD Levy","year":"2001","unstructured":"Levy, B. D., Clish, C. B., Schmidt, B., Gronert, K. & Serhan, C. N. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol. 2, 612\u2013619 (2001).","journal-title":"Nat. Immunol."},{"key":"5800_CR12","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/j.1365-2567.2010.03367.x","volume":"132","author":"Y Sogawa","year":"2011","unstructured":"Sogawa, Y., Ohyama, T., Maeda, H. & Hirahara, K. Inhibition of neutrophil migration in mice by mouse formyl peptide receptors 1 and 2 dual agonist: indication of cross-desensitization in vivo. Immunology 132, 441\u2013450 (2011).","journal-title":"Immunology"},{"key":"5800_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.immuni.2012.03.010","volume":"36","author":"S Uderhardt","year":"2012","unstructured":"Uderhardt, S. et al. 12\/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. Immunity 36, 834\u2013846 (2012).","journal-title":"Immunity"},{"key":"5800_CR14","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1084\/jem.20161070","volume":"214","author":"S Uderhardt","year":"2017","unstructured":"Uderhardt, S. et al. Enzymatic lipid oxidation by eosinophils propagates coagulation, hemostasis, and thrombotic disease. J. Exp. Med. 214, 2121\u20132138 (2017).","journal-title":"J. Exp. Med."},{"key":"5800_CR15","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1084\/jem.9.4.391","volume":"9","author":"EL Opie","year":"1907","unstructured":"Opie, E. L. Experimental pleurisy-resolution of a fibrinous exsudate. J. Exp. Med. 9, 391\u2013413 (1907).","journal-title":"J. Exp. Med."},{"key":"5800_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1189\/jlb.0211062","volume":"90","author":"EE McGrath","year":"2011","unstructured":"McGrath, E. E. et al. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J. Leukoc. Biol. 90, 855\u2013865 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"5800_CR17","doi-asserted-by":"crossref","first-page":"480","DOI":"10.4049\/jimmunol.162.1.480","volume":"162","author":"SB Brown","year":"1999","unstructured":"Brown, S. B. & Savill, J. Phagocytosis triggers macrophage release of Fas ligand and induces apoptosis of bystander leukocytes. J. Immunol. 162, 480\u2013485 (1999).","journal-title":"J. Immunol."},{"key":"5800_CR18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14452","volume":"523","author":"N Gagliani","year":"2015","unstructured":"Gagliani, N. et al. TH17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523, 221\u2013225 (2015).","journal-title":"Nature"},{"key":"5800_CR19","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1126\/science.1087621","volume":"302","author":"MO Li","year":"2003","unstructured":"Li, M. O., Sarkisian, M. R., Mehal, W. Z., Rakic, P. & Flavell, R. A. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science 302, 1560\u20131563 (2003).","journal-title":"Science"},{"key":"5800_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.immuni.2007.11.011","volume":"27","author":"N Kobayashi","year":"2007","unstructured":"Kobayashi, N. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity 27, 927\u2013940 (2007).","journal-title":"Immunity"},{"key":"5800_CR21","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1172\/JCI0211638","volume":"109","author":"ML Huynh","year":"2002","unstructured":"Huynh, M. L., Fadok, V. A. & Henson, P. M. Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J. Clin. Invest. 109, 41\u201350 (2002).","journal-title":"J. Clin. Invest."},{"key":"5800_CR22","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1038\/ng.3947","volume":"49","author":"LA Peters","year":"2017","unstructured":"Peters, L.A. et al. A functional genomics predictive network model identifies regulators of inflammatory bowel disease. Nat. Gen. 49, 1437\u20131449 (2017).","journal-title":"Nat. Gen."},{"key":"5800_CR23","doi-asserted-by":"publisher","first-page":"3605","DOI":"10.4049\/jimmunol.1601330","volume":"198","author":"N Hannemann","year":"2017","unstructured":"Hannemann, N. et al. The AP-1 transcription factor c-Jun promotes arthritis by regulating cyclooxygenase-2 and arginase-1 expression in macrophages. J. Immunol. 198, 3605\u20133614 (2017).","journal-title":"J. Immunol."},{"key":"5800_CR24","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.4049\/jimmunol.1502490","volume":"196","author":"T Varga","year":"2016","unstructured":"Varga, T. et al. Highly dynamic transcriptional signature of distinct macrophage subsets during sterile inflammation, resolution, and tissue repair. J. Immunol. 196, 4771\u20134782 (2016).","journal-title":"J. Immunol."},{"key":"5800_CR25","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature11862","volume":"493","author":"LA O\u2019Neill","year":"2013","unstructured":"O\u2019Neill, L. A. & Hardie, D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346\u2013355 (2013).","journal-title":"Nature"},{"key":"5800_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1146\/annurev-immunol-032713-120236","volume":"32","author":"K Ganeshan","year":"2014","unstructured":"Ganeshan, K. & Chawla, A. Metabolic regulation of immune responses. Annu. Rev. Immunol. 32, 609\u2013634 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"5800_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.immuni.2015.02.017","volume":"42","author":"LA O\u2019Neill","year":"2015","unstructured":"O\u2019Neill, L. A. A broken krebs cycle in macrophages. Immunity 42, 393\u2013394 (2015).","journal-title":"Immunity"},{"key":"5800_CR28","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1042\/BJ20111275","volume":"438","author":"V Infantino","year":"2011","unstructured":"Infantino, V. et al. The mitochondrial citrate carrier: a new player in inflammation. Biochem. J. 438, 433\u2013436 (2011).","journal-title":"Biochem. J."},{"key":"5800_CR29","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cell.2016.08.064","volume":"167","author":"EL Mills","year":"2016","unstructured":"Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167, 457\u2013470 (2016).","journal-title":"Cell"},{"key":"5800_CR30","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/ni.1657","volume":"9","author":"T Rubic","year":"2008","unstructured":"Rubic, T. et al. Triggering the succinate receptor GPR91 on dendritic cells enhances immunity. Nat. Immunol. 9, 1261\u20131269 (2008).","journal-title":"Nat. Immunol."},{"key":"5800_CR31","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496, 238\u2013242 (2013).","journal-title":"Nature"},{"key":"5800_CR32","doi-asserted-by":"publisher","first-page":"7820","DOI":"10.1073\/pnas.1218599110","volume":"110","author":"A Michelucci","year":"2013","unstructured":"Michelucci, A. et al. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. Proc. Natl Acad. Sci. USA 110, 7820\u20137825 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5800_CR33","doi-asserted-by":"crossref","unstructured":"Mills, E. L. et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of Kelch-like ECH-associated protein 1 KEAP1. Nature 556, 113\u2013117 (2018).","DOI":"10.1038\/nature25986"},{"key":"5800_CR34","doi-asserted-by":"publisher","first-page":"16225","DOI":"10.1074\/jbc.M113.454538","volume":"288","author":"Y Li","year":"2013","unstructured":"Li, Y. et al. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J. Biol. Chem. 288, 16225\u201316234 (2013).","journal-title":"J. Biol. Chem."},{"key":"5800_CR35","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.cmet.2016.06.004","volume":"24","author":"V Lampropoulou","year":"2016","unstructured":"Lampropoulou, V. et al. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 24, 158\u2013166 (2016).","journal-title":"Cell Metab."},{"key":"5800_CR36","doi-asserted-by":"publisher","first-page":"11596","DOI":"10.1038\/ncomms11596","volume":"7","author":"Z Chen","year":"2016","unstructured":"Chen, Z. et al. Th2 and eosinophil responses suppress inflammatory arthritis. Nat. Commun. 7, 11596 (2016).","journal-title":"Nat. Commun."},{"key":"5800_CR37","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1126\/science.1201475","volume":"332","author":"D Wu","year":"2011","unstructured":"Wu, D. et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 332, 243\u2013247 (2011).","journal-title":"Science"},{"key":"5800_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20121964","volume":"210","author":"AB Molofsky","year":"2013","unstructured":"Molofsky, A. B. et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210, 535\u2013549 (2013).","journal-title":"J. Exp. Med."},{"key":"5800_CR39","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1096\/fj.11-190934","volume":"26","author":"B Cs\u00f3ka","year":"2012","unstructured":"Cs\u00f3ka, B. et al. Adenosine promotes alternative macrophage activation via A2A and A2B receptors. FASEB J. 26, 376\u2013386 (2012).","journal-title":"FASEB J."},{"key":"5800_CR40","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s10753-013-9771-3","volume":"37","author":"X Mao","year":"2014","unstructured":"Mao, X. et al. Netrin-1 attenuates cardiac ischemia reperfusion injury and generates alternatively activated macrophages. Inflammation 37, 573\u2013580 (2014).","journal-title":"Inflammation"},{"key":"5800_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/ni.3320","volume":"17","author":"Y Okabe","year":"2016","unstructured":"Okabe, Y. & Medzhitov, R. Tissue biology perspective on macrophages. Nat. Immunol. 17, 9\u201317 (2016).","journal-title":"Nat. Immunol."},{"key":"5800_CR42","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nm.4373","volume":"23","author":"S Rauber","year":"2017","unstructured":"Rauber, S. et al. Resolution of inflammation by interleukin 9 producing type 2 innate lymphoid cells. Nat. Med. 23, 938\u2013944 (2017).","journal-title":"Nat. Med."},{"key":"5800_CR43","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/ni.2920","volume":"15","author":"K Gerlach","year":"2014","unstructured":"Gerlach, K. et al. TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cells. Nat. Immunol. 15, 676\u2013686 (2014).","journal-title":"Nat. Immunol."},{"key":"5800_CR44","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00281-016-0601-1","volume":"39","author":"S Koch","year":"2017","unstructured":"Koch, S., Sopel, N. & Finotto, S. Th9 and other IL-9-producing cells in allergic asthma. Semin. Immunopathol. 39, 55\u201368 (2017).","journal-title":"Semin. Immunopathol."},{"key":"5800_CR45","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4049\/jimmunol.1700596","volume":"200","author":"A Soare","year":"2018","unstructured":"Soare, A. et al. Homeostasis of innate lymphoid cells is imbalanced in psoriatic arthritis. J. Immunol. 200, 1249\u20131254 (2018).","journal-title":"J. Immunol."},{"key":"5800_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nature12526","volume":"502","author":"JC Nussbaum","year":"2013","unstructured":"Nussbaum, J. C. et al. Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 502, 245\u2013248 (2013).","journal-title":"Nature"},{"key":"5800_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/nature14115","volume":"519","author":"JR Brestoff","year":"2015","unstructured":"Brestoff, J. R. et al. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature 519, 242\u2013246 (2015).","journal-title":"Nature"},{"key":"5800_CR48","doi-asserted-by":"publisher","first-page":"e0166833","DOI":"10.1371\/journal.pone.0166833","volume":"2016","author":"FP Wang","year":"2016","unstructured":"Wang, F. P., Liu, T., Lan, Z., Li, S. Y. & Mao, H. Efficacy and safety of anti-interleukin-5 therapy in patients with asthma: a systematic review and meta-analysis. PLoS ONE 2016, e0166833 (2016).","journal-title":"PLoS ONE"},{"key":"5800_CR49","unstructured":"Ehrlich, P. Ueber die specifischen Granulationen des Blutes. Archiv fuer Anatomie und Physiologie: Physiologische Abteilung. 571\u2013579 (1879)."},{"key":"5800_CR50","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1096\/fj.10-170027","volume":"25","author":"T Yamada","year":"2011","unstructured":"Yamada, T. et al. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice. FASEB J. 25, 561\u2013568 (2011).","journal-title":"FASEB J."},{"key":"5800_CR51","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1136\/gutjnl-2014-306998","volume":"64","author":"JC Masterson","year":"2015","unstructured":"Masterson, J. C. et al. Eosinophil-mediated signalling attenuates inflammatory responses in experimental colitis. Gut 64, 1236\u20131247 (2015).","journal-title":"Gut"},{"key":"5800_CR52","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1126\/science.1092385","volume":"303","author":"V Brinkmann","year":"2004","unstructured":"Brinkmann, V. et al. Neutrophil extracellular traps kill bacteria. Science 303, 1532\u20131535 (2004).","journal-title":"Science"},{"key":"5800_CR53","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nm.3547","volume":"20","author":"C Schauer","year":"2014","unstructured":"Schauer, C. et al. Aggregated neutrophil extracellular traps limit inflammation by degrading cytokines and chemokines. Nat. Med. 20, 511\u2013517 (2014).","journal-title":"Nat. Med."},{"key":"5800_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/srep43165","volume":"7","author":"T McGarry","year":"2017","unstructured":"McGarry, T. et al. Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in rheumatoid arthritis. Sci. Rep. 7, 43165 (2017).","journal-title":"Sci. Rep."},{"key":"5800_CR55","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/S1471-4906(01)01863-4","volume":"22","author":"CD Buckley","year":"2001","unstructured":"Buckley, C. D. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol. 22, 199\u2013204 (2001).","journal-title":"Trends Immunol."},{"key":"5800_CR56","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.jaci.2011.08.009","volume":"129","author":"GS Whitehead","year":"2012","unstructured":"Whitehead, G. S. et al. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J. Allergy Clin. Immunol. 129, 207\u2013215 (2012).","journal-title":"J. Allergy Clin. Immunol."},{"key":"5800_CR57","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1053\/j.gastro.2011.07.040","volume":"141","author":"S Wirtz","year":"2011","unstructured":"Wirtz, S., Billmeier, U., Mchedlidze, T., Blumberg, R. S. & Neurath, M. F. Interleukin-35 mediates mucosal immune responses that protect against T-cell-dependent colitis. Gastroenterology 141, 1875\u20131886 (2011).","journal-title":"Gastroenterology"},{"key":"5800_CR58","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20091618","volume":"207","author":"T Griseri","year":"2010","unstructured":"Griseri, T. et al. OX40 is required for regulatory T cell-mediated control of colitis. J. Exp. Med. 207, 699\u2013709 (2010).","journal-title":"J. Exp. Med."},{"key":"5800_CR59","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/gut.2005.072801","volume":"55","author":"MC Fantini","year":"2006","unstructured":"Fantini, M. C. Transforming growth factor beta induced FoxP3+regulatory T cells suppress Th1 mediated experimental colitis. Gut 55, 671\u2013680 (2006).","journal-title":"Gut"},{"key":"5800_CR60","doi-asserted-by":"crossref","unstructured":"Desreumaux, P. et al. Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn\u2019s disease. Gastroenterology 143, 1207\u20131217 (2012).","DOI":"10.1053\/j.gastro.2012.07.116"},{"key":"5800_CR61","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.cell.2017.07.027","volume":"171","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Regulatory innate lymphoid cells control innate intestinal inflammation. Cell 171, 201\u2013216 (2017).","journal-title":"Cell"},{"key":"5800_CR62","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.immuni.2012.05.028","volume":"37","author":"AM Hanash","year":"2012","unstructured":"Hanash, A. M. et al. Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37, 339\u2013350 (2012).","journal-title":"Immunity"},{"key":"5800_CR63","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1126\/science.1222551","volume":"336","author":"GF Sonnenberg","year":"2012","unstructured":"Sonnenberg, G. F. et al. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 336, 1321\u20131325 (2012).","journal-title":"Science"},{"key":"5800_CR64","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1136\/gutjnl-2011-300695","volume":"61","author":"R Kiesslich","year":"2012","unstructured":"Kiesslich, R. et al. Local barrier dysfunction identified by confocal laser endomicroscopy predicts relapse in inflammatory bowel disease. Gut 61, 1146\u20131153 (2012).","journal-title":"Gut"},{"key":"5800_CR65","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4049\/jimmunol.1501312","volume":"196","author":"O Medina-Contreras","year":"2016","unstructured":"Medina-Contreras, O. et al. Cutting edge: IL-36 receptor promotes resolution of intestinal damage. J. Immunol. 196, 34\u201338 (2016).","journal-title":"J. Immunol."},{"key":"5800_CR66","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1053\/j.gastro.2017.03.015","volume":"153","author":"MT Chiriac","year":"2017","unstructured":"Chiriac, M. T. et al. Activation of epithelial signal transducer and activator of transcription 1 by interleukin 28 controls mucosal healing in mice with colitis and is increased in mucosa of patients with inflammatory bowel disease. Gastroenterology 153, 123\u2013138 (2017).","journal-title":"Gastroenterology"},{"key":"5800_CR67","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/S0140-6736(17)30182-4","volume":"389","author":"S Paramsothy","year":"2017","unstructured":"Paramsothy, S. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 389, 1218\u20131228 (2017).","journal-title":"Lancet"},{"key":"5800_CR68","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nature15252","volume":"525","author":"Q Zhang","year":"2015","unstructured":"Zhang, Q. et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525, 389\u2013393 (2015).","journal-title":"Nature"},{"key":"5800_CR69","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1172\/JCI90848","volume":"127","author":"P Sadiku","year":"2017","unstructured":"Sadiku, P. et al. Prolyl hydroxylase 2 inactivation enhances glycogen storage and promotes excessive neutrophilic responses. J. Clin. Invest. 127, 3407\u20133420 (2017).","journal-title":"J. Clin. Invest."},{"key":"5800_CR70","doi-asserted-by":"publisher","first-page":"L733","DOI":"10.1152\/ajplung.00419.2015","volume":"310","author":"FR D\u2019Alessio","year":"2016","unstructured":"D\u2019Alessio, F. R. et al. Enhanced resolution of experimental ARDS through IL-4-mediated lung macrophage reprogramming. Am. J. Physiol. Lung Cell Mol. Physiol. 310, L733\u2013L746 (2016).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"5800_CR71","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2131","volume":"12","author":"LA Monticelli","year":"2011","unstructured":"Monticelli, L. A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045\u20131054 (2011).","journal-title":"Nat. Immunol."},{"key":"5800_CR72","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1073\/pnas.1610242114","volume":"114","author":"BA Flitter","year":"2017","unstructured":"Flitter, B. A. et al. Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators. Proc. Natl Acad. Sci. USA 114, 136\u2013141 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5800_CR73","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.immuni.2017.06.021","volume":"47","author":"A Roquilly","year":"2017","unstructured":"Roquilly, A. et al. Local modulation of antigen-presenting cell development after resolution of pneumonia induces long-term susceptibility to secondary infections. Immunity 47, 135\u2013147 (2017).","journal-title":"Immunity"},{"key":"5800_CR74","doi-asserted-by":"crossref","first-page":"17532","DOI":"10.18632\/oncotarget.8162","volume":"7","author":"S Chung","year":"2016","unstructured":"Chung, S. et al. FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype. Oncotarget 7, 17532\u201317546 (2016).","journal-title":"Oncotarget"},{"key":"5800_CR75","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/ni.3421","volume":"17","author":"LA Monticelli","year":"2016","unstructured":"Monticelli, L. A. et al. Arginase 1 is an innate lymphoid-cell-intrinsic metabolic checkpoint controlling type 2 inflammation. Nat. Immunol. 17, 656\u2013665 (2016).","journal-title":"Nat. Immunol."},{"key":"5800_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13944","volume":"8","author":"K Chakraborty","year":"2017","unstructured":"Chakraborty, K. et al. The mito-DAMP cardiolipin blocks IL-10 production causing persistent inflammation during bacterial pneumonia. Nat. Commun. 8, 13944 (2017).","journal-title":"Nat. Commun."},{"key":"5800_CR77","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/j.ajpath.2017.04.012","volume":"187","author":"J McClendon","year":"2017","unstructured":"McClendon, J. et al. Hypoxia-inducible factor 1\u03b1 signaling promotes repair of the alveolar epithelium after acute lung injury. Am. J. Pathol. 187, 1772\u20131786 (2017).","journal-title":"Am. J. Pathol."},{"key":"5800_CR78","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s41232-016-0020-7","volume":"36","author":"M Yamada","year":"2016","unstructured":"Yamada, M., Fujino, N. & Ichinose, M. Inflammatory responses in the initiation of lung repair and regeneration: their role in stimulating lung resident stem cells. Inflamm. Regen. 36, 15 (2016).","journal-title":"Inflamm. Regen."},{"key":"5800_CR79","doi-asserted-by":"publisher","first-page":"15990","DOI":"10.1073\/pnas.1110144108","volume":"108","author":"RL Zemans","year":"2011","unstructured":"Zemans, R. L. et al. Neutrophil transmigration triggers repair of the lung epithelium via \u03b2-catenin signaling. Proc. Natl Acad. Sci. USA 108, 15990\u201315995 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5800_CR80","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.immuni.2016.06.017","volume":"45","author":"I Martinez-Gonzalez","year":"2016","unstructured":"Martinez-Gonzalez, I. et al. Allergen-experienced group 2 innate lymphoid cells acquire memory-like properties and enhance allergic lung inflammation. Immunity 45, 198\u2013208 (2016).","journal-title":"Immunity"},{"key":"5800_CR81","first-page":"2","volume":"10","author":"MG Duvall","year":"2017","unstructured":"Duvall, M. G. et al. Natural killer cell-mediated inflammation resolution is disabled in severe asthma. Sci. Immunol. 10, 2 (2017).","journal-title":"Sci. Immunol."},{"key":"5800_CR82","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1126\/science.2017.6330.355_1169r","volume":"355","author":"A Colmone","year":"2017","unstructured":"Colmone, A. NK cells in severe asthma: failed resolution. Science 355, 1169\u20131171 (2017).","journal-title":"Science"},{"key":"5800_CR83","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.coi.2016.10.001","volume":"43","author":"K Hirahara","year":"2016","unstructured":"Hirahara, K., Schwartz, D., Gadina, M., Kanno, Y. & O\u2019Shea, J. J. Targeting cytokine signaling in autoimmunity: back to the future and beyond. Curr. Opin. Immunol. 43, 89\u201397 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"5800_CR84","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJMoa1513248","volume":"374","author":"WJ Sandborn","year":"2016","unstructured":"Sandborn, W. J. et al. Ozanimod induction and maintenance treatment for ulcerative colitis. N. Engl. J. Med. 374, 1754\u20131762 (2016).","journal-title":"N. Engl. J. Med."},{"key":"5800_CR85","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1136\/flgastro-2016-100720","volume":"8","author":"MA Samaan","year":"2017","unstructured":"Samaan, M. A. et al. Vedolizumab: early experience and medium-term outcomes from two UK tertiary IBD centres. Frontline Gastroenterol. 8, 196\u2013202 (2017).","journal-title":"Frontline Gastroenterol."},{"key":"5800_CR86","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.tips.2015.07.007","volume":"36","author":"M Perretti","year":"2015","unstructured":"Perretti, M., Leroy, X., Bland, E. J. & Montero-Melendez, T. Resolution pharmacology: opportunities for therapeutic innovation in inflammation. Trends Pharmacol. Sci. 36, 737\u2013755 (2015).","journal-title":"Trends Pharmacol. Sci."},{"key":"5800_CR87","doi-asserted-by":"publisher","first-page":"R83","DOI":"10.1186\/ar2717","volume":"11","author":"KR Gheorghe","year":"2009","unstructured":"Gheorghe, K. R. et al. Expression of 5-lipoxygenase and 15-lipoxygenase in rheumatoid arthritis synovium and effects of intraarticular glucocorticoids. Arthritis Res. Ther. 11, R83 (2009).","journal-title":"Arthritis Res. Ther."},{"key":"5800_CR88","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.4049\/jimmunol.162.6.3639","volume":"162","author":"Y Liu","year":"1999","unstructured":"Liu, Y. et al. Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J. Immunol. 162, 3639\u20133646 (1999).","journal-title":"J. Immunol."},{"key":"5800_CR89","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/eji.201445427","volume":"46","author":"EL Mills","year":"2016","unstructured":"Mills, E. L. & O\u2019Neill, L. A. Reprogramming mitochondrial metabolism in macrophages as an anti\u2010inflammatory signal. Eur. J. Immunol. 46, 13\u201321 (2016).","journal-title":"Eur. J. Immunol."},{"key":"5800_CR90","doi-asserted-by":"publisher","first-page":"20348","DOI":"10.1074\/jbc.M115.662114","volume":"290","author":"B Kelly","year":"2015","unstructured":"Kelly, B. et al. Metformin inhibits the production of reactive oxygen species from NADH:ubiquinone oxidoreductase to limit induction of IL\u20101beta, and boosts IL\u201010 in LPS\u2010activated macrophages. J. Biol. Chem. 290, 20348\u201320359 (2015).","journal-title":"J. Biol. Chem."},{"key":"5800_CR91","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1161\/CIRCRESAHA.116.308445","volume":"119","author":"AR Cameron","year":"2016","unstructured":"Cameron, A. R. et al. Anti-inflammatory effects of metformin irrespective of diabetes status. Circ. Res. 119, 652\u2013665 (2016).","journal-title":"Circ. Res."},{"key":"5800_CR92","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cmet.2013.06.017","volume":"18","author":"R Mounier","year":"2013","unstructured":"Mounier, R. et al. AMPKalpha1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration. Cell Metab. 18, 251\u2013264 (2013).","journal-title":"Cell Metab."},{"key":"5800_CR93","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","volume":"369","author":"D de Zeeuw","year":"2013","unstructured":"de Zeeuw, D. et al. Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease. N. Engl. J. Med. 369, 2492\u20132503 (2013).","journal-title":"N. Engl. J. Med."},{"key":"5800_CR94","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1084\/jem.20160061","volume":"213","author":"A Littlewood-Evans","year":"2016","unstructured":"Littlewood-Evans, A. et al. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. J. Exp. Med. 213, 1655\u20131662 (2016).","journal-title":"J. Exp. Med."},{"key":"5800_CR95","doi-asserted-by":"publisher","DOI":"10.1038\/srep43165","volume":"7","author":"T McGarry","year":"2017","unstructured":"McGarry, T. et al. Resolution of TLR2-induced inflammation through manipulation of metabolic pathways in rheumatoid arthritis. Sci. Rep. 7, 43165 (2017).","journal-title":"Sci. Rep."},{"key":"5800_CR96","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.cmet.2014.12.005","volume":"21","author":"EM Palsson\u2010McDermott","year":"2015","unstructured":"Palsson\u2010McDermott, E. M. et al. Pyruvate kinase M2 regulates Hif\u20101alpha activity and IL\u20101beta induction and is a critical determinant of the warburg effect in LPS\u2010activated macrophages. Cell Metab. 21, 65\u201380 (2015).","journal-title":"Cell Metab."},{"key":"5800_CR97","doi-asserted-by":"publisher","first-page":"7671","DOI":"10.1073\/pnas.0409271102","volume":"102","author":"M Arita","year":"2005","unstructured":"Arita, M. et al. Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl Acad. Sci. USA 102, 7671\u20137676 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5800_CR98","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","volume":"405","author":"LV Borovikova","year":"2000","unstructured":"Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458\u2013462 (2000).","journal-title":"Nature"},{"key":"5800_CR99","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1136\/ard.2009.118554","volume":"69","author":"MA van Maanen","year":"2010","unstructured":"van Maanen, M. A., Stoof, S. P., Larosa, G. J., Vervoordeldonk, M. J. & Tak, P. P. Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor \u03b17 subunit gene knockout mice. Ann. Rheum. Dis. 69, 1717\u20131723 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"5800_CR100","doi-asserted-by":"publisher","first-page":"8284","DOI":"10.1073\/pnas.1605635113","volume":"113","author":"FA Koopman","year":"2016","unstructured":"Koopman, F. A. et al. Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 113, 8284\u20138289 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05800-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05800-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05800-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T07:31:27Z","timestamp":1693812687000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-018-05800-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,15]]},"references-count":100,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["5800"],"URL":"https:\/\/doi.org\/10.1038\/s41467-018-05800-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,15]]},"assertion":[{"value":"9 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3261"}}